FiercePharmaOriginal article
{"a":[{"_":"Sanofi opens new chapters in Pfizer, Moderna mRNA patent litigation sagas","$":{"href":"/pharma/sanofi-opens-new-chapters-pfizers-modernas-mrna-patent-litigation-sagas","hreflang":"en"}}]}
Patent ExpiryCOVID-19 vaccinesNegative
AI Analysis
Summary
Sanofi has initiated new patent litigation against Pfizer and Moderna regarding their mRNA COVID-19 vaccines, opening a fresh legal challenge to the companies' intellectual property positions.
Importance:5/10
Sentiment:
-0.30
patent litigationmRNAintellectual propertyCOVID-19 vaccines
Read the original article
Published by FiercePharma on July 15, 2026 3:11 PM